News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
28,007 Results
Type
Article (1017)
Company Profile (1)
Press Release (26989)
Section
Business (6350)
Career Advice (2)
Deals (1123)
Drug Delivery (1)
Drug Development (4070)
Employer Resources (3)
FDA (1553)
Job Trends (624)
News (13304)
Policy (1124)
Tag
Academia (109)
Accelerated approval (1)
Allergies (1)
Alliances (1385)
ALS (3)
Alzheimer's disease (104)
Antibody-drug conjugate (ADC) (2)
Approvals (1594)
Artificial intelligence (6)
Autoimmune disease (2)
Bankruptcy (5)
Best Places to Work (586)
Biosimilars (16)
Biotechnology (1)
Bladder cancer (9)
Brain cancer (2)
Breast cancer (15)
Cancer (140)
Cardiovascular disease (66)
Career advice (2)
Cell therapy (23)
Cervical cancer (1)
Clinical research (3618)
Collaboration (40)
Compensation (12)
COVID-19 (54)
CRISPR (6)
C-suite (24)
Cystic fibrosis (3)
Data (346)
Depression (4)
Diabetes (35)
Diagnostics (139)
Digital health (2)
Drug discovery (4)
Drug pricing (2)
Duchenne muscular dystrophy (2)
Earnings (3067)
Employer resources (3)
Events (3966)
Executive appointments (28)
FDA (1770)
Fibrodysplasia Ossificans Progressiva (2)
Funding (41)
Gene editing (8)
Gene therapy (14)
GLP-1 (10)
Government (92)
Guidances (18)
Healthcare (647)
IgA nephropathy (1)
Immunology and inflammation (3)
Immuno-oncology (3)
Indications (9)
Infectious disease (58)
Inflammatory bowel disease (2)
Intellectual property (11)
IPO (414)
Job creations (75)
Job search strategy (2)
Kidney cancer (1)
Layoffs (5)
Legal (219)
Liver cancer (10)
Lung cancer (21)
Lymphoma (2)
Machine learning (1)
Management (2)
Manufacturing (12)
MASH (9)
Medical device (1686)
Medtech (1690)
Mergers & acquisitions (741)
Metabolic disorders (48)
Multiple sclerosis (2)
NASH (2)
Neurodegenerative disease (12)
Neuroscience (125)
NextGen: Class of 2026 (178)
Non-profit (125)
Obesity (3)
Opinion (2)
Pain (6)
Pancreatic cancer (5)
Parkinson's disease (2)
Partnered (3)
Patents (24)
Patient recruitment (33)
People (1865)
Phase 1 (931)
Phase 2 (1617)
Phase 3 (1295)
Pipeline (287)
Postmarket research (179)
Preclinical (408)
Prostate cancer (4)
Radiopharmaceuticals (4)
Rare diseases (25)
Real estate (124)
Recruiting (1)
Regulatory (1020)
Reports (2)
Research institute (91)
Schizophrenia (2)
Series A (10)
Series B (6)
Sickle cell disease (5)
Startups (137)
Supply chain (1)
Vaccines (8)
Weight loss (1)
Date
Last 7 days (30)
Last 30 days (85)
Last 365 days (1309)
2026 (101)
2025 (1335)
2024 (1351)
2023 (1553)
2022 (2105)
2021 (2020)
2020 (1841)
2019 (1597)
2018 (1267)
2017 (1366)
2016 (1194)
2015 (1558)
2014 (1306)
2013 (992)
2012 (1100)
2011 (1150)
2010 (1125)
Location
Africa (9)
Alabama (3)
Arizona (18)
Asia (1743)
Australia (261)
California (442)
Canada (140)
China (41)
Colorado (10)
Connecticut (5)
Delaware (19)
Europe (3022)
Florida (119)
Georgia (20)
Idaho (1)
Illinois (26)
India (3)
Indiana (4)
Japan (20)
Kansas (9)
Louisiana (1)
Maryland (29)
Massachusetts (346)
Michigan (11)
Minnesota (85)
Missouri (10)
Nevada (8)
New Hampshire (2)
New Jersey (222)
New Mexico (2)
New York (124)
North Carolina (115)
Northern California (268)
Ohio (12)
Oklahoma (1)
Oregon (2)
Pennsylvania (74)
Puerto Rico (3)
Rhode Island (1)
South America (16)
South Carolina (6)
Southern California (95)
Tennessee (5)
Texas (53)
United States (1748)
Utah (14)
Virginia (4)
Washington D.C. (2)
Washington State (12)
West Virginia (1)
28,007 Results for "cagent vascular".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cagent Vascular Initiates the Serranator® POINT FORCE Observational Registry
January 28, 2025
·
2 min read
Press Releases
Cagent Vascular Initiates Patient Enrollment in the Serranator® vs. POBA OCT Study at Columbia University Medical Center
April 10, 2025
·
2 min read
Press Releases
Cagent Vascular Appoints Paul Wilson as Chief Commercial Officer to Drive Growth and Market Expansion
March 5, 2025
·
2 min read
Pharm Country
Cagent Vascular Raises $30 Million Series C Financing
Cagent Vascular, Inc., a rapidly growing commercial stage medical device company, announced a Series C Financing close in excess of $30M. U.S. Venture Partners, led the round.
February 20, 2024
·
3 min read
Press Releases
Cagent Vascular and 3comma Medical Announce Strategic Partnership to Expand International Distribution of Serranator Product Family in EU and MENA Regions
April 3, 2025
·
2 min read
Pharm Country
Cagent Vascular announces initial RECOIL Study results: Serranator demonstrates 49% less recoil than POBA in BTK arteries
Cagent Vascular, the exclusive developer of serration technology for vessel dilatation in endovascular interventions, announced the results of its Below-the-Knee RECOIL study.
July 11, 2023
·
4 min read
Press Releases
Hemostemix Appoints Renowned Vascular Surgeon and Principal Investigator, Dr. York Hsiang, as Business Consultant to Advance First Nations-Led Healthcare Partnerships
February 3, 2026
·
1 min read
Press Releases
Dr. William R. Shankle to Advance ACP-01 as a Treatment for Vascular Dementia
November 20, 2025
·
9 min read
Pharm Country
Cagent Vascular announces superior lumen gain, greater volumetric blood flow using Serration Angioplasty: A sub-analysis of the PRELUDE BTK study
Cagent Vascular, the exclusive developer of Serration Angioplasty (Serranator®), announced the results of a comparative sub-analysis of the PRELUDE-Below-the-Knee (BTK) study versus Plain Old Balloon Angioplasty (POBA).
January 31, 2023
·
4 min read
Press Releases
Feinstein Institutes’ Research Pinpoints Core Cause of Vascular Cognitive Impairment, Unlocking New Therapeutic Avenues for Cognitive Decline
December 8, 2025
·
3 min read
1 of 2,801
Next
